Cathy Scheer

Title: Cathy Scheer: Innovator in Microbial Resistance Detection

Introduction

Cathy Scheer is a prominent inventor based in Omaha, NE (US), known for her significant contributions to the field of microbial resistance detection. With a total of two patents to her name, she has made strides in developing assays and methods that enhance our understanding of antibiotic resistance.

Latest Patents

Cathy's latest patents focus on assays and methods for determining microbial resistance, particularly against beta-lactam antibiotics. These patents include innovative techniques for detecting multiple β-lactamase family-specific gene targets through polymerase chain reaction or microarray. The kits she developed contain primers and/or probes for identifying various β-lactamase genes, such as MOX-like, FOX-like, ACC-like, and many others. Additionally, her work encompasses the identification of non-beta lactamase gene families that confer antibiotic resistance, including the MCR-1 gene.

Career Highlights

Throughout her career, Cathy has worked with notable organizations, including Streck, Inc. and Creighton University. Her experience in these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Cathy has collaborated with several professionals, including Maria Torres-Gonzalez and Nancy D. Hanson. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

Cathy Scheer is a dedicated inventor whose work in microbial resistance detection is paving the way for advancements in antibiotic resistance research. Her innovative patents and collaborations highlight her commitment to improving healthcare outcomes.